Literature DB >> 18491352

Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis.

K Breuhahn1, S Singh, P Schirmacher, H Bläker.   

Abstract

Small intestinal adenocarcinoma is rare and its molecular pathogenesis is incompletely understood. Stabilization of beta-catenin, a mediator of wnt/wingless signalling, can be detected in 50% of sporadic carcinomas but, in contrast to colorectal cancer, this finding can not be explained by the inactivation of adenomatous polyposis coli (APC). In order to elucidate the molecular background of beta-catenin stabilization in small intestinal adenocarcinoma, we investigated 20 non-familial adenomatous polyposis coli (FAP)-associated tumours, including five microsatellite-unstable carcinomas for beta-catenin alterations, by immunohistochemistry, western blot analysis and sequence analysis on the RNA and DNA levels. Nuclear accumulation of beta-catenin was found in 50% of carcinomas. In 30%, nuclear stabilization was restricted to tumour cells at the invasion front, while 20% of tumours displayed intense homogeneous nuclear stabilization throughout all areas. Large deletions and insertions in the beta-catenin gene (CTNNB1) resulting in a partial or complete in-frame loss of exons 3 and 4 on the RNA-transcript level were found in the latter, exclusively microsatellite-stable carcinomas. The mutations resulted in the stabilization of aberrant beta-catenin lacking large parts of N-terminal protein domains. No point mutations in CTNNB1 were observed. Our data show that large intragenic CTNNB1 mutations stabilize beta-catenin in small intestinal adenocarcinomas and influence the subcellular distribution of the protein. In contrast to colon carcinomas, neither APC nor CTNNB1 point mutations seem to play a significant role in carcinogenesis, indicating divergent mechanisms of wnt/wingless control in the small and the large intestine. Copyright (c) 2008 Pathological Society of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18491352     DOI: 10.1002/path.2362

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  6 in total

1.  Small bowel carcinomas in celiac or Crohn's disease: distinctive histophenotypic, molecular and histogenetic patterns.

Authors:  Alessandro Vanoli; Antonio Di Sabatino; Michele Martino; Catherine Klersy; Federica Grillo; Claudia Mescoli; Gabriella Nesi; Umberto Volta; Daniele Fornino; Ombretta Luinetti; Paolo Fociani; Vincenzo Villanacci; Francesco P D'Armiento; Renato Cannizzaro; Giovanni Latella; Carolina Ciacci; Livia Biancone; Marco Paulli; Fausto Sessa; Massimo Rugge; Roberto Fiocca; Gino R Corazza; Enrico Solcia
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

2.  β-catenin dosage is a critical determinant of tracheal basal cell fate determination.

Authors:  Heather M Brechbuhl; Moumita Ghosh; Mary Kathryn Smith; Russell W Smith; Bilan Li; Douglas A Hicks; Brook B Cole; Paul R Reynolds; Susan D Reynolds
Journal:  Am J Pathol       Date:  2011-05-05       Impact factor: 4.307

Review 3.  [Chromosomal instability, microsatellite instability and CpG island methylator phenotype: roles in small intestinal carcinogenesis].

Authors:  H Bläker; A Warth; M Kloor; P Schirmacher
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

4.  Small bowel adenocarcinoma in Crohn's disease: a systematic review and meta-analysis of the prevalence, manifestation, histopathology, and outcomes.

Authors:  Yip Han Chin; Sneha Rajiv Jain; Ming Hui Lee; Cheng Han Ng; Snow Yunni Lin; Aaron Shengting Mai; Mark Dhinesh Muthiah; Fung Joon Foo; Raghav Sundar; David Eng Hui Ong; Wei Qiang Leow; Rupert Leong; Webber Pak Wo Chan
Journal:  Int J Colorectal Dis       Date:  2021-10-26       Impact factor: 2.571

Review 5.  Clinical practice guidelines for duodenal cancer 2021.

Authors:  Kenji Nakagawa; Masayuki Sho; Mitsuhiro Fujishiro; Naomi Kakushima; Takahiro Horimatsu; Ken-Ichi Okada; Mikitaka Iguchi; Toshio Uraoka; Motohiko Kato; Yorimasa Yamamoto; Toru Aoyama; Takahiro Akahori; Hidetoshi Eguchi; Shingo Kanaji; Kengo Kanetaka; Shinji Kuroda; Yuichi Nagakawa; Souya Nunobe; Ryota Higuchi; Tsutomu Fujii; Hiroharu Yamashita; Suguru Yamada; Yukiya Narita; Yoshitaka Honma; Kei Muro; Tetsuo Ushiku; Yasuo Ejima; Hiroki Yamaue; Yasuhiro Kodera
Journal:  J Gastroenterol       Date:  2022-10-19       Impact factor: 6.772

Review 6.  Small bowel adenocarcinomas--existing evidence and evolving paradigms.

Authors:  Kanwal Raghav; Michael J Overman
Journal:  Nat Rev Clin Oncol       Date:  2013-07-30       Impact factor: 66.675

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.